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Retinal vascular diameter in young subjects
with a vasospastic propensity
Abstract Purpose: Retinal vascular
diameters have recently been shown
not to be related to an increased risk
of open-angle glaucoma. Because
vasospastic propensity has been sug-
gested to represent a risk factor for
various ocular diseases, especially
glaucoma, the steady-state retinal
vascular diameter in subjects with a
propensity for systemic vascular dys-
regulation was compared with a group
of age-matched gender-matched con-
trols. Methods: Thirty healthy non-
smoking individuals [female/male
26/4; mean ± SD age 22.8±3.4 (range
18–31) years] were enrolled into the
study. Subjects were classified as
having vasospasm (15 subjects) if
they related a clear history of fre-
quently cold hands and as healthy
subjects (15 subjects) if they denied
such a history. Vasospastic propen-
sity or the absence of it had to be
confirmed by nail-fold capillaroscopy.
Vascular diameter of retinal vessels
was measured repeatedly on two days
with the retinal vessel analyser and
corrected for perfusion pressure, age,
and refraction. Results: Neither ret-
inal arteriole diameter (P=0.30) or
retinal venule diameter (P=0.49),
nor retinal arteriole-to-venule ratio
(P=0.96), differed between the two
experimental groups. Conclusions:
Although vasospastic propensity has
been suggested to represent a risk
factor in various ocular diseases, the
steady-state retinal vessel diameters
are not altered in healthy vasospastic
subjects. It is probable that the steady-
state retinal vessel diameters are no
adequate risk indicators for the hae-
modynamic risk in diseases such as
glaucoma.
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Introduction
Structural changes in the retinal vasculature have long been
advocated to represent important predictors of systemic
vascular disease [37]. However, qualitative assessment of
retinal vessels, using ophthalmoscopy, has a poor reproduc-
ibility [4]. More recent studies have demonstrated that
retinal microvasculature may show abnormalities related to
elevated concurrent blood pressure in older people [25, 39,
42] and to cardiovascular complications [6, 26, 27, 38, 40,
41, 43, 44]. From a functional perspective, diseases with
vascular dysregulation have been reported to induce vaso-
spasms in the retinal vessels [2, 17, 24], and retinal blood
flow abnormalities have been reported in otherwise healthy
subjects with a propensity for systemic vascular dysregula-
tion [13]. It has been suggested that such alterations may
play a role in the pathogenesis of glaucoma [8, 13] and also
in other ocular diseases [9]. Notwithstanding, a recent
study suggested that baseline retinal vessel diameters do
not predict the incidence of glaucomatous changes in the
optic disc [21]. However, the latter study included only
subjects aged at least 55 years, possibly excluding patients
who may have developed glaucoma from vascular dys-
regulation at an earlier age. Therefore, the diameter of the
F. Branca . S. Orgül (*) . C. Zawinka .
G. Reinhard . J. Flammer
University Eye Clinic of Basel,
Mittlere Strasse 91,
P.O Box 4012 Basle, Switzerland
e-mail: sorguel@uhbs.ch
Tel.: +41-61-2658633
Fax: +41-61-2658745
retinal vessels in otherwise healthy young vasospastic sub-
jects was compared with a group of age-matched gender-
matched controls in a pilot study.
Patients and methods
Thirty healthy non-smoking individuals, 26 female and
four male [mean ± SD age 22.8±3.4 (range 18–31) years]
were enrolled into the study. All procedures conformed to
the Declaration of Helsinki. After approval by the ethics
committee, we obtained informed consent from the sub-
jects. A notification in the University Eye Clinic of Basel
informed potential volunteers (collaborators, students, par-
ents and friends of patients) of the opportunity to partici-
pate in a scientific research project. Subjects were screened
for ocular and systemic diseases. A detailed medical and
ophthalmic history was recorded, and all subjects com-
pleted an ophthalmological examination. Included were
only individuals with no history of ocular or systemic dis-
ease, no history of chronic or current systemic or topical
medication, and no history of drug or alcohol abuse.
Further inclusion criteria were a normal systolic (100–
140 mmHg) and diastolic (60–90 mmHg) blood pressure,
a best-corrected visual acuity above 20/25 in both eyes,
ametropia within −3 to +3 dioptres of spherical equivalent
and less than 1 dioptre astigmatism in each eye, an intra-
ocular pressure (IOP) lower than 20 mmHg in each eye by
(Goldman) aplanation tonometry, and no pathological
findings after slit-lamp examination and indirect fundus-
copy.
Subjects were classified as having vasospasm if they
related a clear history of frequently cold hands (answering
“yes” to the questions: “do you always have cold hands,
even during the summer?” and “do other people tell you
that you have cold hands?”) and as healthy subjects if they
reported no such history. Vasospastic propensity or the
absence of it had to be confirmed by nail-fold capillaros-
copy, the examiner being unaware of the history of cold
hands. Subjects with contradictory findings from nail-fold
capillaroscopy and history or describing “sometimes having
cold hands” were excluded from the present analysis.
Nail-fold capillaroscopy
Nail-fold capillaroscopy was performed in a room with a
constant temperature of approximately 23°C (range 21–
25°C). Prior to the examination, the hands of the subjects
were warmed in a water bath of 40°C. The skin of the nail-
fold was made transparent by a drop of oil, rendering the
capillaries running parallel to the skin surface and the flow
of cellular elements visible under a light microscope. A
microscope coupled to a TV monitor, which was coupled
to a video-recorder, allowing the observed blood flow to
be videotaped and to be analysed off-line was used. After
baseline flow measurement, the nail-fold area was cooled
at −15°C for 60 s by rapidly decompressing carbon di-
oxide, and the occurrence of blood flow standstill was
recorded. A closure of one or more visible capillaries with
an average stop-time longer than 12 s was defined as a
vasospastic reaction [29].
Retinal vascular diameter
Vascular diameter of retinal vessels was measured with the
retinal vessel analyser (Imdeos, Jena, Germany), a com-
mercially available device allowing high precision with
coefficients of variation for repeated measurements below
3% [33, 35]. The retinal vessel analyser (RVA) comprises
a fundus camera, a video-camera, a real-time monitor, and
a personal computer with analysing software for the ac-
curate determination of retinal arteriole and venule di-
ameters. Retinal vessel diameters are analysed in real time
with a maximum frequency of 50 Hz. For this purpose
the fundus is imaged onto the charge-coupled device chip
of the video-camera. The consecutive fundus images are
digitised by a frame grabber. In addition, the fundus image
can be inspected on the real-time monitor and, if necessary,
stored on a video-recorder, allowing either on-line or off-
line evaluation.
Measurement of retinal vessel diameters is based on
adaptive algorithms using the specific absorbing properties
of haemoglobin. A region of interest is defined by a rect-
angle on the screen of the real-time monitor, within which
the retinal vessel diameter is calculated along the entire
vascular segment. This window can include a retinal ar-
teriole, a retinal venule, or both. The system is able auto-
matically to correct for alterations in luminance as induced,
for instance, by slight eye movements, and the system
automatically stops the measurement during blinks. To
correct for magnification error, we estimated the optic disc
size in each subject at the slit-lamp with a Volk 60 D lens
[34]. To establish the correspondence between measure-
ments and dimensions in the eye, we assumed that the
diameter of the average optic nerve head was 1,850 μm
in the eye [20]. The relationship between these estimates
of optic disc size was used as the basis for correcting for
magnification error.
Experimental procedures
After evaluation of inclusion criteria and nail-fold capil-
laroscopy, two days of experiment, 1 week apart, were
scheduled for each subject.
On each day of experiment, retinal vessel diameters were
measured in the morning, after the subject had fasted for
12 h overnight, in one randomly chosen eye (the same eye
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on both days of experiment). Participants were instructed to
abstain from a large meal, alcohol consumption (including
alcohol-containing products and drugs), and physical exer-
cise for 24 h prior to the measurements. On the days of the
experiments, the subjects were seated for 30 min in the
laboratory, and local tropicamid was applied in one eye
thrice every 5 min for pupil dilation. Blood pressure was
measured every 10 min for at least 30 min. After stabili-
sation of blood pressure, retinal vessel diameter was as-
sessed. The fellow eye was covered to improve fixation
during imaging with the fundus camera. The image of the
retina was adjusted on the screen of the real-time monitor,
and a region of interest was laid over a 1–1.5 mm-long
segment of the inferior major temporal branch arteriole.
The measurement site was located at least half a disc
diameter away from the margin of the optic disc. The
average measurement time was approximately 1 min. The
recordings were stored on a videotape, and the inferior
major temporal branch venule was evaluated off-line at the
same distance from the disc as the arteriole. Following
retinal vessel assessment, blood pressure was measured by
sphygmomanometry and intraocular pressure was mea-
sured by Goldmann aplanation tonometry, after the ap-
plication of one drop of 0.4% benoxinate hydrochloride
and the staining of the tear film with a strip of fluorescein
sodium.
Ocular perfusion pressure (OPP) was calculated by the
following formula: OPP ¼ 2=3 2=3½ð DBPþ 1=3  SBPÞ
IOP where DBP, SBP, and IOP represent diastolic blood
pressure, systolic blood pressure, and intraocular pressure,
respectively.
Particular emphasis was put on ensuring the same
measurement conditions at the two sessions, especially for
the adjustment of brightness control. All measurements
executed with the RVA were performed by the same ex-
perienced researcher, who, as the investigator doing nail-
fold capillaroscopy, was blind to the vasospastic propensity
of the subjects. For the second measurements, the in-
vestigator was blind to the selection of the region of interest
in the first measurement. We obtained the second mea-
surements in order to account for the variation of the
placement of the measurement window between partici-
pants, as well as for physiological variation of retinal vessel
diameter. In order to ascertain that repeated measurements
were obtained at comparable conditions, we excluded sub-
jects showing a change of more than 8% between the first
and the second measurements.
Although this was a pilot study, sample size calculations
were applied. The variability for measurements of the ar-
teriolar diameter was considered for power calculations,
because its measurement is prone to a higher variability
[33, 35]. Based on four unpublished series of measure-
ments, the average within-group variability was estimated
to be 12% of the mean. For a statistical power of 80% and a
probability of 5%, to find a difference between groups of
13% (slightly higher than the within-group variability), we
needed to recruit 14 subjects for each group.
We performed a two-way analysis of variance (vaso-
spastic subjects/non-vasospastic subjects × measurement 1/
measurement 2), with the two sessions set as repeated
measurements, to compare retina arteriolar and venular
vessel diameters, as well as the arteriole-to-venule ratio
(arteriole diameter/venule diameter) between vasospastic
subjects and controls, after correcting the measurements for
perfusion pressure, age, and refraction. A P value of 0.05
was considered significant.
Results
Ten subjects were excluded because of inconsistent find-
ings between history and nail-fold capillaroscopy, five be-
cause of bad recordings in nail-fold capillaroscopy, seven
because of bad recordings, and three because of a high
differences in RVA measurements between the two days of
experiment. Recruitment was pursued until 15 vasospastic
and 15 age-matched controls had been identified. Age was
23.0±3.3 years in vasospastic subjects and 22.7±3.6 years
in controls (P=0.78). Spherical equivalent for refraction
was −0.50±1.28 dioptres in vasospastic subjects and −0.79±
1.19 dioptres in controls (P=0.53).
IOP, SBP, DBP and OPP are detailed in Table 1 for both
measurement sessions. None of the haemodynamic param-
eters, evaluated in a two-way analysis of variance model
(vasospastic subjects/non-vasospastic subjects × measure-
ment 1/measurement 2) with the two sessions set as re-
peated measurements, showed a difference between the
two experimental groups (P=0.96, P=0.65, and P=0.82 for
SBP, DBP and OPP, respectively). There was no statistical
difference between the two sessions (P=0.19, P=0.21, and
P=0.30, respectively), and the two experimental groups
were comparable in this regard (interaction between ex-
perimental groups and repeated measurements: Pv=0.77,
P=0.58, and P=0.51, respectively). IOP in contrast, was
Table 1 Intraocular pressure, systolic blood pressure, diastolic
blood pressure, and perfusion pressure at both measurement sessions
(mean ± SD)
Parameter Session Vasospastic
subjects
Controls
Intraocular pressure
(mmHg)
1 12.2+1.5 13.6+1.9
2 12.1+1.5 13.3+1.7
Systolic blood pressure
(mmHg)
1 115.8+13.4 115.2+12.3
2 113.7+14.7 113.8+12.56
Diastolic blood pressure 1 74.1+10.4 75.2+9.7
2 72.3+10.7 74.5+9.7
Perfusion pressure
(mmHg)
1 46.5±6.9 45.4±7.0
2 45.3±7.2 45.2±6.8
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lower in vasospastic subjects (P=0.04), with no statistical
difference between the two sessions (P=0.16) and no sta-
tistical significant interaction between experimental groups
and repeated measurements (P=0.35).
The measurements for the diameters for the arterioles,
the venules, and the arteriole-to-venule ratio were corrected
for the potential influence of age, perfusion pressure and
refraction. The values are detailed in Table 2 for both
measurement sessions. Evaluation of the corrected val-
ues in a two-way analysis of variance model (vasospastic
subjects/non-vasospastic subjects × measurement 1/mea-
surement 2), with the two sessions set as repeated mea-
surements, showed no difference between the groups
(P=0.30), and there was no statistical difference between
the two sessions (P=0.28), the two experimental groups
behaving similarly in this regard (interaction between ex-
perimental groups and repeated measurements P=0.48).
Retinal venule diameter, evaluated in a similar model,
showed no difference between the groups (P=0.49) or be-
tween the two sessions (P=0.94), and there was no inter-
action between the experimental groups and the repeated
measurements (P=0.54). Similarly, retinal arteriole-to-
venule ratio showed no difference between the groups
(P=0.96) or between the two sessions (P=0.70), and there
was no interaction between the experimental groups and
the repeated measurements (P=0.99). A comparison of the
diameters for the arterioles, the venules, and the arteriole-
to-venule ratio, without correction for the potential in-
fluence of age, ocular perfusion pressure and refraction,
did not alter these findings.
Discussion
The present study demonstrated that retinal vascular diam-
eter is not altered in young and otherwise healthy va-
sospastic subjects. All the vascular measurements were
compared after correction for ocular perfusion pressure,
age or refraction, but, except for a lower IOP in vasospastic
subjects, all factors potentially having some bearing on the
retinal vascular diameter, especially ocular perfusion pres-
sure, were comparable between the experimental groups.
The vasospastic syndrome is a condition manifesting
as reversible, local or generalised arteriolar constrictions
(vasospasms) or inadequate dilation [9], possibly due to a
vascular endotheliopathy [19, 28, 32] and often associated
with vasospastic reactions to cold in the nail-fold capil-
laries, as assessed by nail-fold capillaroscopy [29]. The
primary vasospastic syndrome is encountered more often
in women than in men, and is characterised by a tendency
towards cold hands. The vascular attacks can be provoked
by many factors, such as exposure to cold, stress, emo-
tions and nicotine. The observation of parallel changes in
peripheral blood flow (fingers) and visual field in vaso-
spastic patients [16] led to the definition of an entity called
“presumed ocular vasospastic syndrome” [7]. Additional
studies led further support to the idea that some paral-
lelisms in ocular and digital blood flow exist [11, 15] and
that the presumed ocular vasospastic syndrome is asso-
ciated with a lack of blood flow autoregulation [12, 14,
18]. Ocular vasospastic phenomena have also been ob-
served directly in patients with unstable primary angina
[2] and with migraine [24]. Ocular vasospastic phenomena
have been advocated to be a potential risk factor in various
ocular conditions, including glaucoma [1], retinal venous
occlusion [30], acute ischaemic optic neuropathy [23], and
central serous chorioretinopathy [36].
The retinal vessel diameter was assessed with the RVA,
a device allowing a high precision for repeated measure-
ments [33, 35] and for which a good ability to detect
changes after interventions has been demonstrated [10, 22,
31]. Furthermore, Dorner et al. [5] calculated the diameter
of the central retinal artery based on retinal blood flow
velocity measurements obtained by laser Doppler velo-
cimetry and colour Doppler imaging as well as retinal
venous diameter measurements with the RVA. Their results
were in good agreement to in vitro measurements, sug-
gesting a good ability for the RVA to estimate the retinal
vascular diameter. Although vessel diameter assessments
were based on measurements obtained in 1 min, which
prevented vascular pulsation from having a relevant in-
fluence on the results, other physiological parameters, for
example hormonal effects [3], as well as variability in
alignment of the measurement window were likely to
influence the measurements and have a relevant bearing on
a small sample. For this reason, repeated measurements
were obtained on two different days, 1 week apart, and only
repeated measurements with a fair reproducibility were
considered in the present study. Tropicamid was used to
dilate the pupils and, although this substance was not
expected to have a vascular effect, one may have to con-
sider a possible effect of this drug on vessel diameter.
However, because it was used equally in both groups, it
seems unlikely that this substance may have influenced the
presented results. A limitation in our study is the fact that
only one pair of vessels was assessed within a defined
distance from the optic disc. It is thinkable that vessels of a
Table 2 Diameters of retinal arterioles and venules, and arteriole-
to-venule ratio at both measurement sessions (mean ± SD)
Parameter Session Vasospastic
subjects
Controls
Arteriolar diameters (μm) 1 126.8±14.7 121.2±15.5
2 127.6±16.1 121.3±15.8
Venular diameters (μm) 1 154.7±16.4 150.3±22.8
2 155.1±15.4 149.7±21.3
Arteriolar-to-venular ratio 1 0.83±0.09 0.82±0.1
2 0.83±0.1 0.83±0.1
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smaller calibre, or those in the upper retina, may be more
prone to disclose differences between the analysed sub-
jects. Further investigations are needed to evaluate the
regional importance of alterations in the calibre of retinal
vessels.
The current study suggests that, under steady-state con-
ditions, the retinal vasculature of otherwise healthy vaso-
spastic subjects does not illustrate distinctive features in
retinal vascular diameter. A recently published prospective
study showed that both retinal arteriole and venule di-
ameters are not related to an increased risk of open-angle
glaucoma [21]. Because vasospastic propensity has been
suggested to represent a risk factor for various ocular dis-
eases, especially glaucoma [9], the present findings suggest
that the assessment of the retinal vascular diameter may not
be an adequate approach to assess the haemodynamic risk
in glaucoma patients.
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